Company Overview
We are a leader in Oculomics and create next-gen population-based solutions that enable early disease interception
We Are Excited to Revolutionize Disease Detection with Point of Care Vital Health Screenings Focused on Oculomics.
Oculomics uses the eye as a window into the health of the whole body. The retina, for example, is a direct extension of the brain and contains a dense network of blood vessels and nerves that are sensitive to changes in the body. These changes can reflect early warning signs of various conditions long before symptoms appear elsewhere.
We operate at the convergence of MedTech and Healthtech.
Our robust turnkey retinal screening solution allows point-of-care providers to better evaluate their patients.
- Vitazi-MD™ is our telehealth solution.
- Vitazi-DR™ is our autonomous (AI) solution and is currently in a clinical trial in the US and used in Mexico.
- Going beyond-our platform has the potential to intercept numerous diseases.
Installation of our system primary care practices, clinical lab testing sites, retail pharmacy clinics and integrated health systems will facilitate access and increase compliance for vital eye screenings to reduce disease burden through early disease interception.
Our platform provides a range of benefits for providers such as seamless system integration, no upfront costs, additional revenue opportunities, while reducing work burden and enhancing patient care.
Market Opportunity & Financial Projections
DR Screening Market
$B
Prediabetic and diabetic
US total addressable market
$B
Type 2 Diabetes
US serviceable addressable market currently diagnosed diabetic
$M
US Vitazi.ai’s obtainable market
25% of market share due to unique solution
Diabetes Is only Our First Application.
It is only scratching the surface because the eye is a window to a person’s overall health. Several other eye, cardiovascular, and neurological diseases can cause changes in the eye which can be detected by oculomics through imaging and measurement techniques.
Oculomics Market
We’re focusing on Oculomics.
Not only is Oculomics projected to significantly grow, but AI in healthcare is also estimated to grow over 1,400% by 2029.
$B
2021
$B
2028